Department of Urology, Ganzhou People's Hospital, 17 Hongqi Avenue, Ganzhou, Jiangxi, 341000, China.
BMC Urol. 2024 Oct 24;24(1):234. doi: 10.1186/s12894-024-01628-z.
To explore the feasibility and safety of aflexible ureteroscopy with intelligent control of renal pelvic pressure(FUS-ICP) without a post-operative indwelling urinary catheter .
In this retrospective study, we assessed patients with upper urinary tract stones who were treated with FUS-ICP at the Ganzhou People's Hospital from February 2022 to December 2023. Patients were divided into the non-urinary catheter (non-UC) and urinary catheter (UC) groups according to whether an indwelling catheter was used after surgery.
In total, 142 patients were included in the study. There was no significant difference in the preoperative general data between the two groups. Patients in the non-UC group performed better than those in the UC group in terms of catheter-related bladder irritation (P = 0.001), the Sedation-Agitation Scale score (P = 0.012), and the numerical rating scale (P = 0.003). The incidences of urinary retention (P = 0.620), urinary tract infection (P = 0.529), and replacement of urethral catheter s (P = 0.438) in the UC group were inferior to those in the non-UC group, but there was no statistical significance.
It is feasible and safe to perform FUS-ICP without a post-procedure indwelling urinary catheter.
探讨智能控制肾盂压力下（FUS-ICP）软性输尿管镜术而无需术后留置导尿管的可行性和安全性。
本回顾性研究评估了 2022 年 2 月至 2023 年 12 月在赣州市人民医院接受 FUS-ICP 治疗的上尿路结石患者。根据术后是否留置导尿管，将患者分为非留置导尿管（非 UC）和留置导尿管（UC）组。
共有 142 例患者纳入研究。两组患者术前一般资料无统计学差异。非 UC 组患者在导管相关膀胱刺激方面（P=0.001）、镇静躁动评分（P=0.012）和数字评分量表（P=0.003）方面优于 UC 组。UC 组的尿潴留（P=0.620）、尿路感染（P=0.529）和更换尿道导管（P=0.438）发生率低于非 UC 组，但无统计学意义。
FUS-ICP 术后无需留置导尿管是可行且安全的。
